SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013040
Filing Date
2022-05-12
Accepted
2022-05-12 16:16:19
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 577862
2 ex31-1.htm EX-31.1 13339
3 ex31-2.htm EX-31.2 13019
4 ex32-1.htm EX-32.1 11220
5 form10-q_002.jpg GRAPHIC 103442
  Complete submission text file 0001493152-22-013040.txt   3344371

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pcsa-20220331.xsd EX-101.SCH 30374
7 XBRL CALCULATION FILE pcsa-20220331_cal.xml EX-101.CAL 39723
8 XBRL DEFINITION FILE pcsa-20220331_def.xml EX-101.DEF 108755
9 XBRL LABEL FILE pcsa-20220331_lab.xml EX-101.LAB 250136
10 XBRL PRESENTATION FILE pcsa-20220331_pre.xml EX-101.PRE 187511
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 319955
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39531 | Film No.: 22918015
SIC: 2834 Pharmaceutical Preparations